Literature DB >> 27347056

Blastic plasmacytoid dendritic cell neoplasm: A case report and literature review.

Yi-Wei Zhang1, Ji-Hua Zhong1, Xiao-Long Chen1, Fei Xiao1, Fang-Yuan Chen1.   

Abstract

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive tumor, which frequently presents as cutaneous lesions and subsequently progresses to bone marrow (BM) involvement and leukemic dissemination. BPDCN is a rare entity that belongs in the same class as acute myeloid leukemia-associated precursor neoplasms, according to the 2008 World Health Organization classification. The present study reported the case of a 26-year-old female who presented with evident thrombocytopenia, leukocytosis and anemia, but without skin lesions. The results of peripheral blood, BM smear and BM biopsy examinations detected numerous blastic or abnormal cells. In addition, flow cytometric analysis of BM demonstrated the presence of plasmacytoid dendritic cell-neoplastic precursor cells (CD4+, CD56+, CD123+, CD304+ and human leukocyte antigen-DR+ phenotype).

Entities:  

Keywords:  dendritic cell; neoplasm; plasmacytoid

Year:  2016        PMID: 27347056      PMCID: PMC4906920          DOI: 10.3892/etm.2016.3259

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  13 in total

1.  Blastic plasmacytoid dendritic cell neoplasia (BPDC) in elderly patients: results of a treatment algorithm employing allogeneic stem cell transplantation with moderately reduced conditioning intensity.

Authors:  Sascha Dietrich; Mindaugas Andrulis; Ute Hegenbart; Thomas Schmitt; Frauke Bellos; Uwe M Martens; Julia Meissner; Alwin Krämer; Anthony D Ho; Peter Dreger
Journal:  Biol Blood Marrow Transplant       Date:  2011-01-06       Impact factor: 5.742

Review 2.  Natural killer cell neoplasm: biology and pathology.

Authors:  Maria Francisca Ham; Young-Hyeh Ko
Journal:  Int J Hematol       Date:  2010-12-07       Impact factor: 2.490

3.  CD4(+) CD56(+) lineage-negative malignancies are rare tumors of plasmacytoid dendritic cells.

Authors:  Kaaren K Reichard; Eric J Burks; M Kathryn Foucar; Carla S Wilson; David S Viswanatha; John C Hozier; Richard S Larson
Journal:  Am J Surg Pathol       Date:  2005-10       Impact factor: 6.394

Review 4.  CD4+/CD56+ hematodermic tumor: the features of an evolving entity and its relationship to dendritic cells.

Authors:  Marco Herling; Dan Jones
Journal:  Am J Clin Pathol       Date:  2007-05       Impact factor: 2.493

5.  Clinical and biologic features of CD4(+)CD56(+) malignancies.

Authors:  Jean Feuillard; Marie-Christine Jacob; Françoise Valensi; Marc Maynadié; Rémy Gressin; Laurence Chaperot; Christine Arnoulet; Françoise Brignole-Baudouin; Bernard Drénou; Eliane Duchayne; Annie Falkenrodt; Richard Garand; Emanuelle Homolle; Bernard Husson; Emilienne Kuhlein; Geneviève Le Calvez; Danielle Sainty; Marie-France Sotto; Franck Trimoreau; Marie-Christine Béné
Journal:  Blood       Date:  2002-03-01       Impact factor: 22.113

Review 6.  Blastic plasmacytoid dendritic cell neoplasm with leukemic presentation, lacking cutaneous involvement: Case series and literature review.

Authors:  Michael J Rauh; Fazlur Rahman; David Good; Jeffrey Silverman; Michael K Brennan; Nikolay Dimov; Jane Liesveld; Daniel H Ryan; W Richard Burack; John M Bennett
Journal:  Leuk Res       Date:  2011-09-03       Impact factor: 3.156

7.  Blastic plasmacytoid dendritic cell neoplasm in children: diagnostic features and clinical implications.

Authors:  Armin G Jegalian; Nataliya P Buxbaum; Fabio Facchetti; Mark Raffeld; Stefania Pittaluga; Alan S Wayne; Elaine S Jaffe
Journal:  Haematologica       Date:  2010-07-27       Impact factor: 9.941

Review 8.  CD4+/CD56+ hematodermic neoplasm: presentation of 2 cases and review of the concept of an uncommon tumor originated in plasmacytoid dendritic cells expressing CD123 (IL-3 receptor alpha).

Authors:  Sergio Piña-Oviedo; Hector Herrera-Medina; Heliodoro Coronado; Luis Del Valle; Carlos Ortiz-Hidalgo
Journal:  Appl Immunohistochem Mol Morphol       Date:  2007-12

Review 9.  Plasmacytoid dendritic cells: physiologic roles and pathologic states.

Authors:  Armin G Jegalian; Fabio Facchetti; Elaine S Jaffe
Journal:  Adv Anat Pathol       Date:  2009-11       Impact factor: 3.875

10.  Blastic plasmacytoid dendritic cell neoplasm.

Authors:  André Lencastre; Joana Cabete; Alexandre João; Pedro Farinha; Gilda Ferreira; Sara Lestre
Journal:  An Bras Dermatol       Date:  2013 Nov-Dec       Impact factor: 1.896

View more
  2 in total

1.  Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report and Clinicopathological Review.

Authors:  Marwa Mohammed Abdel Fattah Zaki; Khaled Zalata; Amira Kamal El-Hawary; Noha Eisa; Shaimaa El Ashwah; Sameh Shamaa
Journal:  J Hematol (Brossard)       Date:  2018-09-01

Review 2.  Clinicopathologic retrospective analysis of blastic plasmacytoid dendritic cell neoplasms.

Authors:  Agnieszka Owczarczyk-Saczonek; Małgorzata Sokołowska-Wojdyło; Berenika Olszewska; Marta Malek; Aleksandra Znajewska-Pander; Anna Kowalczyk; Wojciech Biernat; Grażyna Poniatowska-Broniek; Wanda Knopińska-Posłuszny; Zygmunt Kozielec; Roman Nowicki; Waldemar Placek
Journal:  Postepy Dermatol Alergol       Date:  2018-04-24       Impact factor: 1.837

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.